bullish
high
✓ Verified against BSE filing
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Q3 FY25
R&D spend guidance of 8.5%-9% for FY25
Management expects full-year R&D investment to be in the range of 8.5% to 9% of sales.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1
Q3 FY25
SG&A expenses to remain around 28% of sales
Management indicated SG&A as a percentage of sales will stay at current levels (~28%) going forward.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1